Commons report caps HITF with focus on UK medical technology access
This article was originally published in Clinica
Executive Summary
Device evaluation, procurement policy, tariffs, investment in medical technology and R&D are among the leading topics of the UK House of Commons Health Committee's eagerly-awaited report on "The use of new medical technologies within the NHS". But any sceptics ready to dismiss UK procurement and access problems and issues as a fait accompli, in the wake of the Healthcare Industries Task Force, will be surprised to find that the parliamentary report not only complements HITF, but also provides a timely focus on its potential shortcomings.